Marshall Wace, LLP Atai Life Sciences N.V. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Marshall Wace, LLP holds 793,839 shares of ATAI stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
793,839
Previous 775,889
2.31%
Holding current value
$1.03 Million
Previous $1.09 Million
42.87%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ATAI
# of Institutions
96Shares Held
13.1MCall Options Held
229KPut Options Held
114K-
Morgan Stanley New York, NY2.67MShares$3.47 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.22MShares$2.88 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.4MShares$1.82 Million0.0% of portfolio
-
Brown University719KShares$934,0500.61% of portfolio
-
Round Table Services, LLC704KShares$915,2000.46% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $216M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...